Om Prakash

694 total citations
42 papers, 468 citations indexed

About

Om Prakash is a scholar working on Infectious Diseases, Oncology and Modeling and Simulation. According to data from OpenAlex, Om Prakash has authored 42 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 11 papers in Oncology and 8 papers in Modeling and Simulation. Recurrent topics in Om Prakash's work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (12 papers) and COVID-19 epidemiological studies (8 papers). Om Prakash is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (12 papers) and COVID-19 epidemiological studies (8 papers). Om Prakash collaborates with scholars based in India, United States and Netherlands. Om Prakash's co-authors include Fokhrul Hossain, Lucio Miele, Richard Scribner, Denise Danos, Adam Lassak, Sukdeb Pal, Deepak Panchal, Prakash Bobde, Anil Gupta and Man Mohan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Om Prakash

37 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Om Prakash India 11 145 107 71 67 65 42 468
Vanesa Balboa‐Barreiro Spain 14 122 0.8× 104 1.0× 55 0.8× 55 0.8× 32 0.5× 65 619
Julia M. Cruz United States 15 273 1.9× 76 0.7× 75 1.1× 65 1.0× 85 1.3× 36 758
Ida Hed Myrberg Sweden 14 74 0.5× 90 0.8× 70 1.0× 39 0.6× 22 0.3× 35 454
Mohammed Khattab Morocco 12 106 0.7× 38 0.4× 112 1.6× 55 0.8× 19 0.3× 30 588
Thomas Böhler Germany 14 75 0.5× 109 1.0× 180 2.5× 102 1.5× 39 0.6× 49 629
Lennard Y. W. Lee United Kingdom 12 104 0.7× 229 2.1× 63 0.9× 78 1.2× 13 0.2× 34 492
Tong Deng China 12 101 0.7× 59 0.6× 102 1.4× 52 0.8× 46 0.7× 33 486
Jeong Youn Lim United States 12 121 0.8× 18 0.2× 59 0.8× 38 0.6× 43 0.7× 43 517
Jiraporn Srinakarin Thailand 9 118 0.8× 27 0.3× 33 0.5× 50 0.7× 29 0.4× 27 331
Dara Lundon United States 15 138 1.0× 100 0.9× 80 1.1× 54 0.8× 51 0.8× 65 656

Countries citing papers authored by Om Prakash

Since Specialization
Citations

This map shows the geographic impact of Om Prakash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Om Prakash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Om Prakash more than expected).

Fields of papers citing papers by Om Prakash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Om Prakash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Om Prakash. The network helps show where Om Prakash may publish in the future.

Co-authorship network of co-authors of Om Prakash

This figure shows the co-authorship network connecting the top 25 collaborators of Om Prakash. A scholar is included among the top collaborators of Om Prakash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Om Prakash. Om Prakash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Prakash, Om, et al.. (2022). Immunoglobulin-G Antibodies against Severe Acute Respiratory Syndrome – Coronavirus-2 among Health-Care Workers. International Journal of Applied and Basic Medical Research. 12(1). 18–23. 1 indexed citations
5.
Prakash, Om, et al.. (2021). Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study. BMJ Open. 11(1). e044101–e044101. 14 indexed citations
6.
Prakash, Om, et al.. (2021). Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city. Journal of Family Medicine and Primary Care. 10(6). 2363–2368. 5 indexed citations
7.
Prakash, Om, et al.. (2021). Severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody: Seroprevalence among contacts of COVID-19 cases. Indian Journal of Public Health. 65(1). 5–5. 6 indexed citations
8.
Panchal, Deepak, Om Prakash, Prakash Bobde, & Sukdeb Pal. (2021). SARS-CoV-2: sewage surveillance as an early warning system and challenges in developing countries. Environmental Science and Pollution Research. 28(18). 22221–22240. 43 indexed citations
9.
Prakash, Om, et al.. (2021). SARS-CoV2 IgG antibody: Seroprevalence among health care workers. Clinical Epidemiology and Global Health. 11. 100766–100766. 7 indexed citations
10.
Prakash, Shantanu, Om Prakash, Kiran Rade, et al.. (2021). Feasibility, efficiency & effectiveness of pooled sample testing strategy (pooled NAAT) for molecular testing of COVID-19. The Indian Journal of Medical Research. 153(1-2). 227–232. 4 indexed citations
11.
Prakash, Om, et al.. (2021). Seroprevalence of Immunoglobulin-G Antibody Among Confirm Cases of COVID-19. Cureus. 13(9). e17956–e17956. 1 indexed citations
12.
Prakash, Om, Fokhrul Hossain, Denise Danos, et al.. (2020). Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors. Frontiers in Public Health. 8. 576964–576964. 86 indexed citations
13.
Jain, Parul, et al.. (2020). Identification of SARS-CoV-2 clusters from symptomatic cases in India. The Indian Journal of Medical Research. 152(1-2). 111–115. 2 indexed citations
14.
Prakash, Shantanu, et al.. (2020). SARS-CoV-2 –RNA persists longer in faecal sample as compared to nasal and throat swab samples of COVID-19 patients’; an observational study. Indian Journal of Medical Microbiology. 39(1). 122–124. 4 indexed citations
15.
Hossain, Fokhrul, Denise Danos, Om Prakash, et al.. (2019). Neighborhood Social Determinants of Triple Negative Breast Cancer. Frontiers in Public Health. 7. 18–18. 50 indexed citations
16.
Marrero, Luis, Dorota Wyczechowska, Anna Wilk, et al.. (2014). Therapeutic Efficacy of Aldoxorubicin in an Intracranial Xenograft Mouse Model of Human Glioblastoma. Neoplasia. 16(10). 874–882. 31 indexed citations
17.
Babu, Kalpana, et al.. (2009). Role of the Mantoux Test and Treatment with Antitubercular Therapy in a South Indian Patient Population of Presumed Intraocular Tuberculosis. Ocular Immunology and Inflammation. 17(5). 307–311. 10 indexed citations
18.
Tulpule, Anil, Bharat Joshi, Byron M. Espina, et al.. (1997). Interleukin-4 in the treatment of AIDS-related Kaposi’s sarcoma. Annals of Oncology. 8(1). 79–83. 26 indexed citations
19.
Prakash, Om, et al.. (1993). Significance of serum immunoglobulin levels in conglomeration with trans-sternal phlebography in the phlebography management of breast cancer.. PubMed. 36(1). 21–7. 3 indexed citations
20.
Prakash, Om, Pieter D. Verdouw, Jan Willem de Jong, et al.. (1980). Haemodynamic and biochemical variables after induction of anaesthesia with fentanyl and nitrous oxide in patients undergoing coronary artery by-pass surgery. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 27(3). 223–229. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026